BDBM326663 US9662327, Compound 329
SMILES: CCCCOC(=O)N1CCN(CC1C(=O)OCC)c1nc(C(C)C)c2COC(C)(C)Cc2c1C#N
InChI Key: InChIKey=LPNUTUJQSWDCJP-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IDH1 R132H (Homo sapiens (Human)) | BDBM326663![]() (US9662327, Compound 329) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Agios Pharmaceuticals Inc US Patent | Assay Description Assays were conducted in a volume of 76 μl assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in ... | US Patent US9662327 (2017) BindingDB Entry DOI: 10.7270/Q2RB76P0 | |||||||||||
More data for this Ligand-Target Pair |